Rice Hall James & Associates, LLC Aerie Pharmaceuticals Inc Transaction History

Rice Hall James & Associates, LLC

$1.69 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	SELL	$6.37 - $15.23 $1.54 Million - $3.67 Million	-241,169 Reduced 13.07%	1,603,458 $24.3 Million
Q2 2022 Aug 08, 2022	BUY	$4.95 - $9.16 $821,789 - $1.52 Million	166,018 Added 9.89%	1,844,627 $13.8 Million
Q1 2022 May 05, 2022	BUY	$5.64 - $9.8 $2.68 Million - $4.66 Million	475,017 Added 39.47%	1,678,609 $15.3 Million
Q4 2021 Feb 14, 2022	SELL	$7.02 - $13.33 $203,636 - $386,676	-29,008 Reduced 2.35%	1,203,592 $8.45 Million
Q3 2021 Nov 09, 2021	SELL	$11.32 - $16.63 $91,499 - $134,420	-8,083 Reduced 0.65%	1,232,600 $14.1 Million
Q2 2021 Jul 29, 2021	SELL	$15.16 - $18.97 $2.39 Million - $2.99 Million	-157,383 Reduced 11.26%	1,240,683 $19.9 Million
Q1 2021 May 14, 2021	BUY	$13.12 - $20.9 $381,240 - $607,312	29,058 Added 2.12%	1,398,066 $25 Million
Q4 2020 Feb 16, 2021	SELL	$9.12 - $14.49 $393,710 - $625,533	-43,170 Reduced 3.06%	1,369,008 $18.5 Million
Q3 2020 Nov 16, 2020	BUY	$10.46 - $14.46 $1.62 Million - $2.25 Million	155,260 Added 12.35%	1,412,178 $16.6 Million
Q2 2020 Aug 14, 2020	SELL	$12.0 - $16.13 $350,556 - $471,205	-29,213 Reduced 2.27%	1,256,918 $18.6 Million
Q1 2020 May 15, 2020	BUY	$11.84 - $25.52 $2.05 Million - $4.43 Million	173,404 Added 15.58%	1,286,131 $17.4 Million
Q4 2019 Jan 29, 2020	BUY	$17.72 - $25.1 $6.89 Million - $9.77 Million	389,102 Added 53.77%	1,112,727 $26.9 Million
Q3 2019 Oct 30, 2019	BUY	$18.41 - $28.0 $3.41 Million - $5.19 Million	185,376 Added 34.44%	723,625 $13.9 Million
Q2 2019 Aug 01, 2019	BUY	$28.97 - $48.21 $144,618 - $240,664	4,992 Added 0.94%	538,249 $15.9 Million
Q1 2019 May 01, 2019	BUY	$36.32 - $49.25 $2.75 Million - $3.73 Million	75,752 Added 16.56%	533,257 $25.3 Million
Q4 2018 Feb 14, 2019	BUY	$33.0 - $60.04 $5.92 Million - $10.8 Million	179,432 Added 64.53%	457,505 $16.5 Million
Q3 2018 Oct 25, 2018	SELL	$56.15 - $73.9 $375,587 - $494,317	-6,689 Reduced 2.35%	278,073 $17.1 Million
Q2 2018 Aug 02, 2018	BUY	$47.85 - $70.45 $457,589 - $673,713	9,563 Added 3.47%	284,762 $19.2 Million
Q1 2018 Apr 25, 2018	BUY	$51.15 - $61.0 $308,843 - $368,318	6,038 Added 2.24%	275,199 $14.9 Million
Q4 2017 Jan 23, 2018	BUY	$50.85 - $65.1 $1.73 Million - $2.21 Million	33,927 Added 14.42%	269,161 $16.1 Million
Q3 2017 Oct 30, 2017	BUY	$48.6 - $60.1 $11.4 Million - $14.1 Million	235,234	235,234 $11.4 Million

Others Institutions Holding AERI

# of Institutions

Shares Held

2.4M

Call Options Held

Put Options Held

View Full List

About AERIE PHARMACEUTICALS INC

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

More about AERI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.

Account